An ALDH1A3 inhibitor
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

KOTX1

Item No. 42249

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
3-ethyl-N-(7-fluoro-1,2,3,4-tetrahydro-2-oxo-6-quinolinyl)-4-pyridinecarboxamide
CAS Number
1788963-83-6
Molecular Formula
C17H16FN3O2
Formula Weight
313.3
Purity
≥95%
Formulation
A solid
Solubility(Learn about Variance in Solubility)
Acetonitrile: Slightly soluble: 0.1-1 mg/mlWater: Slightly soluble: 0.1-1 mg/ml
SMILES
FC1=C(C=C2C(NC(CC2)=O)=C1)NC(C3=C(CC)C=NC=C3)=O
InChi Code
InChI=1S/C17H16FN3O2/c1-2-10-9-19-6-5-12(10)17(23)21-15-7-11-3-4-16(22)20-14(11)8-13(15)18/h5-9H,2-4H2,1H3,(H,20,22)(H,21,23)
InChi Key
QJJWNFKDFKNPEV-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    1 mg

    $61

    Add

    5 mg

    $273

    Add

    10 mg

    $484

    Add
    Cayman Chemical
    Explore Obesity & Metabolic Disease Resources

    Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.

    OBESITY RESEARCH SOLUTIONS
    Product Description

    KOTX1 is an inhibitor of aldehyde dehydrogenase 1A3 (ALDH1A3; IC50 = 5.14 nM).1 It potentiates glucose-induced insulin secretion from pancreatic islets isolated from patients with type 2 diabetes when used at a concentration of 10 µM. KOTX1 (40 mg/kg per day) decreases plasma insulin levels and reduces blood glucose levels in an intraperitoneal glucose tolerance test (IPGTT) in diabetic db/db male mice. It decreases blood glucose levels and increases plasma insulin levels in a mouse model of obesity induced by a high-fat diet when administered in the diet at 270 ppm.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Son, J., Du, W., Esposito, M., et al. Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure. Nat. Commun. 14(1), 558 (2023).